In this article you are going to find out whether hedge funds think Tellurian Inc. (NASDAQ:TELL) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […]...
In this article you are going to find out whether hedge funds think Hoegh LNG Partners LP (NYSE:HMLP) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus […]...
Are you familiar with Ocugen (NASDAQ:OCGN), the penny stock that took a massive plunge in 2019? OCGN stock closed near $14 on Sept. 26. Three sessions later, it closed at $2.19.Source: Shutterstock The stock has been on a painful descent since then, most recently closing at 25 cents. Currently, Ocugen sports a 52-week range of 17 cents to $21.60. That's quite the range, but not unheard of when it comes to small biotech stocks.All of this action comes after its deal with Histogenic. Ocugen is the result of an all-stock deal, where 90% of the combined entity went to shareholders of the privately held Ocugen. The combined entity continued business under the Ocugen name, which simply adds another layer into this interesting arrangement.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny for Your ThoughtsHere's the deal. I'm generally optimistic about the reopening of the world. We're seeing more people...
In this article you are going to find out whether hedge funds think National Grid plc (NYSE:NGG) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks […]...
From a fundamental perspective, I have not been a big fan of Inovio Pharmaceuticals (NASDAQ:INO). However, INO stock has continued to sport very solid technicals.Source: Ascannio / Shutterstock.com I have long believed that combining the two studies can yield superior results. When a stock has excellent fundamentals and excellent technicals, it can be a potent recipe for a higher stock price.Inovio may not have the fundamentals that we want, but it's chart sure looks good. Let's look at this one from a trading perspective first.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Trading INO Stock Click to EnlargeSource: Chart courtesy of StockCharts.com This stock erupted in March, bursting from $4 to almost $20 in just a few days. After pulling back and settling in, it was clear that $9.50 was resistance for INO stock. * 7 Great Biotech Stocks to Buy and Hold Now While the stock struggled to...
